Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Salomon

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Nature Medicine|November 8, 2006
Melanoma pathogenesis and Nodal: a partial picture?David S Salomon
Expert Opinion on Therapeutic Patents|November 16, 2010
Targeting the embryonic gene Cripto-1 in cancer and beyondCaterina Bianco, David S Salomon
Expert Opinion on Therapeutic Patents|May 16, 2009
Human Cripto-1 as a target for a cancer vaccine: WO2008040759Caterina Bianco, David S Salomon
Biochemical and Biophysical Research Communications|November 9, 2010
Intercellular transfer regulation of the paracrine activity of GPI-anchored Cripto-1 as a Nodal co-receptorKazuhide Watanabe, David S Salomon
Journal of Mammary Gland Biology and Neoplasia|August 10, 2004
Embryogenesis and oncogenesis: Dr Jekyll and Mr HydeDavid S Salomon, Michael T Lewis
Cell Cycle (Georgetown, Tex.)|January 25, 2011
miR-31 in cancer: location mattersChristina H Stuelten, David S Salomon
Aging|August 24, 2015
Cripto-1 in TNBCNadia P Castro, David S Salomon
Journal of Cellular Physiology|February 22, 2002
Cripto: a tumor growth factor and moreEileen D Adamson, Gabriella Minchiotti, David S Salomon
Stem Cells (Dayton, Ohio)|May 7, 2009
Re: "Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells-implications for pregnancy-induced protection against breast cancer" by Siwko et alGilbert H Smith, David S Salomon, Barbara K Vonderhar
Growth Factors (Chur, Switzerland)|November 3, 2004
Role of the cripto (EGF-CFC) family in embryogenesis and cancerCaterina Bianco, Nicola Normanno, David S Salomon, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Nature Medicine|November 8, 2006
Melanoma pathogenesis and Nodal: a partial picture?David S Salomon
Expert Opinion on Therapeutic Patents|November 16, 2010
Targeting the embryonic gene Cripto-1 in cancer and beyondCaterina Bianco, David S Salomon
Expert Opinion on Therapeutic Patents|May 16, 2009
Human Cripto-1 as a target for a cancer vaccine: WO2008040759Caterina Bianco, David S Salomon
Biochemical and Biophysical Research Communications|November 9, 2010
Intercellular transfer regulation of the paracrine activity of GPI-anchored Cripto-1 as a Nodal co-receptorKazuhide Watanabe, David S Salomon
Journal of Mammary Gland Biology and Neoplasia|August 10, 2004
Embryogenesis and oncogenesis: Dr Jekyll and Mr HydeDavid S Salomon, Michael T Lewis
Cell Cycle (Georgetown, Tex.)|January 25, 2011
miR-31 in cancer: location mattersChristina H Stuelten, David S Salomon
Aging|August 24, 2015
Cripto-1 in TNBCNadia P Castro, David S Salomon
Journal of Cellular Physiology|February 22, 2002
Cripto: a tumor growth factor and moreEileen D Adamson, Gabriella Minchiotti, David S Salomon
Stem Cells (Dayton, Ohio)|May 7, 2009
Re: "Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells-implications for pregnancy-induced protection against breast cancer" by Siwko et alGilbert H Smith, David S Salomon, Barbara K Vonderhar
Growth Factors (Chur, Switzerland)|November 3, 2004
Role of the cripto (EGF-CFC) family in embryogenesis and cancerCaterina Bianco, Nicola Normanno, David S Salomon, et al.
Pageof 9